[
    {
        "content": "* Q3 earnings per share view $0.30 -- Thomson Reuters I/B/E/S",
        "date": "11082017",
        "name": "Globus Medical Inc",
        "news_type": "topStory",
        "symbol": "GMED",
        "title": "BRIEF-Globus Medical reports Q3 earnings per share $0.26 "
    },
    {
        "content": "* Globus Medical announces first spine surgeries using ExcelsiusGPS",
        "date": "10102017",
        "name": "Globus Medical Inc",
        "news_type": "topStory",
        "symbol": "GMED",
        "title": "BRIEF-Globus Medical \u200dexpects first revenues from sale of ExcelsiusGPS systems in Q4 2017 "
    },
    {
        "content": "* Globus Medical Inc - \u200dPaul will remain in role of executive chairman\u200b",
        "date": "08292017",
        "name": "Globus Medical Inc",
        "news_type": "topStory",
        "symbol": "GMED",
        "title": "BRIEF-Globus Medical appoints David Demski as CEO "
    },
    {
        "content": "* Globus Medical announces FDA 510(k) clearance for Excelsius GPS\u2122 Source text for Eikon: Further company coverage:",
        "date": "08172017",
        "name": "Globus Medical Inc",
        "news_type": "topStory",
        "symbol": "GMED",
        "title": "BRIEF-Globus Medical announces FDA 510(k) clearance for Excelsius GPS "
    },
    {
        "content": "* Globus Medical - received  letter from FDA informing co had not sufficiently addressed questions regarding 510(K) submission for Excelsiusgps",
        "date": "05172017",
        "name": "Globus Medical Inc",
        "news_type": "topStory",
        "symbol": "GMED",
        "title": "BRIEF-Globus Medical says received letter from FDA regarding 510(K) submission for Excelsiusgps "
    },
    {
        "content": "* Q1 earnings per share view $0.31 -- Thomson Reuters I/B/E/S",
        "date": "05032017",
        "name": "Globus Medical Inc",
        "news_type": "topStory",
        "symbol": "GMED",
        "title": "BRIEF-Globus Medical reports Q1 earnings per share of $0.30 "
    },
    {
        "content": "* Globus Medical - Anticipates filing its form 10-K for the fiscal year ended December 31  2016 within the extension period  Source text: [http://bit.ly/2mK6X85] Further company coverage:",
        "date": "03012017",
        "name": "Globus Medical Inc",
        "news_type": "topStory",
        "symbol": "GMED",
        "title": "BRIEF-Globus Medical files for non-timely 10-K "
    },
    {
        "content": "* Globus medical reports full year and fourth quarter 2016 results",
        "date": "02272017",
        "name": "Globus Medical Inc",
        "news_type": "topStory",
        "symbol": "GMED",
        "title": "BRIEF-Globus Medical Q4 non-gaap EPS  $0.31 "
    },
    {
        "content": " ",
        "date": "01122017",
        "name": "Globus Medical Inc",
        "news_type": "topStory",
        "symbol": "GMED",
        "title": "Globus medical sees FY 2016 sales up 3.5 pct to $625 mln "
    },
    {
        "content": "* Q3 revenue $135.7 million versus i/b/e/s view $139.2 million",
        "date": "11082016",
        "name": "Globus Medical Inc",
        "news_type": "topStory",
        "symbol": "GMED",
        "title": "BRIEF-Globus Medical reports Q3 earnings per share $0.27 "
    },
    {
        "content": "* Q3 revenue $135.7 million versus I/B/E/S view $139.2 million",
        "date": "11082016",
        "name": "Globus Medical Inc",
        "news_type": "normal",
        "symbol": "GMED",
        "title": "BRIEF-Globus Medical reports Q3 adj. earnings per share $0.29 "
    },
    {
        "content": "* Says entered into a credit  security and guaranty agreement with Alphatec And Alphatec Spine  Inc.",
        "date": "09022016",
        "name": "Globus Medical Inc",
        "news_type": "topStory",
        "symbol": "GMED",
        "title": "BRIEF-Globus Medical enters agreement with Alphatec and Alphatec Spine "
    },
    {
        "content": "* Preliminarily projects 2017 full year sales of $640M including $40M from acquisition",
        "date": "07262016",
        "name": "Globus Medical Inc",
        "news_type": "topStory",
        "symbol": "GMED",
        "title": "BRIEF-Globus Medical Q2 non-gaap earnings per share $0.29 "
    },
    {
        "content": "* Alphatec Holdings announces sale of international business to Globus Medical",
        "date": "07262016",
        "name": "Globus Medical Inc",
        "news_type": "normal",
        "symbol": "GMED",
        "title": "BRIEF-Alphatec Holdings announces sale of international business to Globus Medical "
    },
    {
        "content": "* Globus Medical announces the acquisition of Alphatec's international business",
        "date": "07262016",
        "name": "Globus Medical Inc",
        "news_type": "normal",
        "symbol": "GMED",
        "title": "BRIEF-Globus Medical to buy Alphatec's international business for $80 mln in cash "
    },
    {
        "content": "* Bonutti Skeletal Innovations Llc entered into a settlement and license agreement with Globus Medical Inc - sec filing",
        "date": "06102016",
        "name": "Globus Medical Inc",
        "news_type": "topStory",
        "symbol": "GMED",
        "title": "BRIEF-Acacia Research says Bonutti Skeletal Innovations entered into settlement  license agreement with Globus Medical "
    },
    {
        "content": "* Globus Medical appoints Eric Ian Schwartz as senior vice president and general counsel  Source text for Eikon:  Further company coverage:    (Bengaluru Newsroom: +1 646 223 8780)",
        "date": "05102016",
        "name": "Globus Medical Inc",
        "news_type": "topStory",
        "symbol": "GMED",
        "title": "BRIEF-Globus Medical appoints Eric Ian Schwartz as senior vice president  general counsel "
    },
    {
        "content": "* Q1 earnings per share view $0.28 -- Thomson Reuters I/B/E/S",
        "date": "05032016",
        "name": "Globus Medical Inc",
        "news_type": "topStory",
        "symbol": "GMED",
        "title": "BRIEF-Globus Medical reports Q1 earnings per share $0.29 "
    }
]